Bionano Genomics, Inc. (BNGO) Financials
BNGO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 181.9 million | 62.9 million |
2023-06-30 | 271.4 million | 56.6 million |
2023-03-31 | 292.2 million | 60.7 million |
2022-12-31 | 307.5 million | 58.1 million |
BNGO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -26.4 million | 4.0 million |
2023-06-30 | -37.2 million | 3.9 million |
2023-03-31 | -32.8 million | 3.9 million |
2022-12-31 | -36.1 million | 5.5 million |
BNGO Net Income
No data available :(
BNGO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 63.6 million | - | 10.1 million |
2023-06-30 | 77.1 million | - | 10.7 million |
2023-03-31 | 95.8 million | - | 11.2 million |
2022-12-31 | 113.2 million | - | 11.7 million |
BNGO Shares Outstanding
BNGO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 75000 | 13.8 million | 24.9 million | - |
2023-06-30 | 511000 | 14.6 million | 26.9 million | - |
2023-03-31 | 360000 | 13.9 million | 26.0 million | - |
2022-12-31 | 1.6 million | 14.0 million | 25.3 million | - |
BNGO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 9.3 million | 6.6 million |
2023-06-30 | 8.7 million | 6.4 million |
2023-03-31 | 7.4 million | 5.3 million |
2022-12-31 | 8.2 million | 6.4 million |
BNGO
Price: $0.86
52 week price:
Earnings Per Share: -6.81 USD
P/E Ratio: -0.16
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 6.9 million
Market Capitalization: 55.8 million